-transparent.png){kind=logo}
The effect of newly-developed anti-arrhythmia drug Bonnecor compared to that of ethacizin and lidocaine has been studied on anesthetized rats under acute myocardial ischemia. The drugs injected intravenously prior to coronary artery occlusion have been shown to prevent to a great degree the appearance of hemodynamic and functional disturbances of the heart. When compared to control, less reduction in systemic arterial pressure, systolic discharge cardiac output, contractility and heart power were observed. In addition, Bonnecor has been found to have certain advantages over reference drugs.
Related Publications
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
January 1990,
Farmakologiia i toksikologiia,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
January 1990,
Farmakologiia i toksikologiia,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
January 1990,
Farmakologiia i toksikologiia,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
December 1996,
Biulleten' eksperimental'noi biologii i meditsiny,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
January 1993,
Kardiologiia,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
January 1990,
Farmakologiia i toksikologiia,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
August 1986,
Kardiologiia,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
December 1989,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
December 1990,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
E A Tolmacheva, and
G G Chichkanov, and
D D Matsievskiĭ
February 1990,
Klinicheskaia meditsina,
